Observational analysis reveals MSMP promotes aberrant fibroblast-like synoviocyte behavior in rheumatoid arthritis, suggesting new therapeutic targets.
Key Points
MSMP levels are significantly elevated in fibroblast-like synoviocytes from rheumatoid arthritis patients, impacting joint deterioration.
Key findings indicate that MSMP knockdown significantly reduces RA fibroblast-like synoviocytes' migration and invasion capabilities.
Utilizing RNA expression analysis and protein assays, this study identifies RUNX1 as a transcription factor regulating GPR137B involved in MSMP signaling.
Intra-articular treatment with Ad-shRNA-MSMP showed potential to alleviate arthritis severity in a collagen-induced arthritis model.